PTEN状态,瘤免疫微环境,以及结直肠癌的生存率
Joni Karjalainen1, Onni Sirkiä2, Päivi Sirniö1
1Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Aapistie 5A, 90220, Oulu, Finland.
Virchows Archiv : an international journal of pathology
|November 18, 2025
概括
酸酶和素同类素 (PTEN) 损失不能预测结直肠癌 (CRC) 的预后,也与瘤免疫微环境无关. 单独的PTEN免疫组织化学作为CRC中的生物标志物具有有限的临床实用性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 酸酶和张素同类基因 (PTEN) 是一个关键的瘤抑制基因.
- 在各种癌症中,PTEN损失与不良预后和免疫治疗反应有关.
- 它在结直肠癌 (CRC) 预后和免疫微环境中的作用尚不清楚.
研究的目的:
- 调查PTEN表达在结直肠癌中的预后意义.
- 探索PTEN状态和CRC中的瘤免疫微环境之间的关联.
主要方法:
- 在两个大型CRC队列 (N=2303) 中,使用免疫组织化学评估PTEN表达.
- 多重免疫组织化学被用来分析免疫细胞组成和免疫抑制标记物.
- 统计分析评估了PTEN表达状态的预后价值和免疫相关性.
主要成果:
- 在两个队列中,在11-12%的CRC瘤中观察到PTEN损失.
- PTEN表达状态没有显示出对整体或CRC特定死亡率的显著预后价值.
- PTEN损失与BRAF突变和不匹配修复缺陷相关,但与关键免疫标记物 (PD-L1,PD-1,IDO,ARG1) 不相关.
结论:
- 在结直肠癌中,PTEN免疫组织化学缺乏预后价值.
- PTEN表达状态并不反映CRC中的瘤免疫格局.
- 仅PTEN免疫组织化学作为CRC中的生物标志物具有有限的临床实用性,这表明需要进行综合基因组分析.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
14.3K
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
1.9K
相关概念视频
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K